Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ginkgo Bioworks Holdings Inc. (DNA)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 19
  • 1 comments

Ginkgo Bioworks Awarded Project Agreement through BARDAs BioMaP-Consortium

Market reaction Comment Full text

MediWound Ltd. (MDWD)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 7
  • 1 comments

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Market reaction Comment Full text

Nautilus Biotechnology Inc (NAUT)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 13
  • 1 comments

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

Market reaction Comment Full text

Nexgel Inc (NXGLW)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 18
  • 1 comments

NEXGEL to Report Third Quarter 2025 Financial Results on November 11th

Market reaction Comment Full text

Estrella Immunopharma Inc. (ESLA)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 17
  • 1 comments

Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients

Market reaction Comment Full text

Liquidia Corporation (LQDA)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 18
  • 1 comments

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Market reaction Comment Full text

Milestone Pharmaceuticals Inc (MIST)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 20
  • 1 comments

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Nov. 03, 2025, 13:00 UTC
  • 16
  • 1 comments

Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis

Market reaction Comment Full text

Clearbridge Health Limited (1H3)

  • Business News
  • Nov. 03, 2025, 12:59 UTC
  • 17
  • 1 comments

Clearbridge Health launches adult immune cell banking business, targets Southeast Asia and Hong Kong

Market reaction Comment Full text

Pfizer Inc (PFE)

  • Business News
  • Nov. 03, 2025, 12:57 UTC
  • 16
  • 1 comments

Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk

Market reaction Comment Full text
  • Previous
  • 916
  • 917
  • 918
  • 919
  • 920
  • Next

Search

News categories

  • Technical Exchange News(11010)
  • Event(2495)
  • SEC News(195068)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126810)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin